Literature DB >> 15221201

Functional MRI study of working memory in MDMA users.

F Gerard Moeller1, Joel L Steinberg, Donald M Dougherty, Ponnada A Narayana, Larry A Kramer, Perry F Renshaw.   

Abstract

RATIONALE: Methylene-dioxymethamphetamine (MDMA) is known to cause degeneration of serotonin nerve terminals after acute doses in animals. Similarly, behavioral studies in human MDMA users regularly find abnormalities in memory, mood, and impulse control. However, studies of brain function using brain imaging in MDMA users have been less consistent.
OBJECTIVES: The purpose of this study was to determine, using functional magnetic resonance imaging (fMRI), whether individuals with a self-reported history of MDMA use would differ from non-MDMA using controls on activation while performing a working memory task.
METHODS: Fifteen MDMA using subjects and 19 non-MDMA using controls underwent fMRI scanning while performing the immediate and delayed memory task (IMT/DMT). The study was based on a block design in which the delayed memory task (DMT) alternated with the immediate memory task (IMT), which served as a control condition. FMRI scans were acquired on a 1.5 T scanner, using a gradient echo echoplanar pulse sequence.
RESULTS: Random effects SPM99 analysis showed significantly greater activation (whole volume corrected cluster P<0.05) during the DMT relative to the IMT in the MDMA subjects compared with the control subjects in the medial superior frontal gyrus, in the thalamus extending into putamen, and in the hippocampus.
CONCLUSIONS: Although these effects could be due to other drugs used by MDMA users, these results are consistent with behavioral problems that are associated with MDMA use, and with animal studies on the effects of MDMA on brain function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15221201     DOI: 10.1007/s00213-004-1908-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  45 in total

1.  Reorganization of frontal systems used by alcoholics for spatial working memory: an fMRI study.

Authors:  A Pfefferbaum; J E Desmond; C Galloway; V Menon; G H Glover; E V Sullivan
Journal:  Neuroimage       Date:  2001-07       Impact factor: 6.556

2.  Studies on the neuroprotective effect of the enantiomers of AR-A008055, a compound structurally related to clomethiazole, on MDMA ("ecstasy")-induced neurodegeneration in rat brain.

Authors:  M I Colado; E O'Shea; B Esteban; A R Green
Journal:  Psychopharmacology (Berl)       Date:  2001-08       Impact factor: 4.530

3.  Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI study.

Authors:  L Chang; C S Grob; T Ernst; L Itti; F S Mishkin; R Jose-Melchor; R E Poland
Journal:  Psychiatry Res       Date:  2000-02-28       Impact factor: 3.222

4.  Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users.

Authors:  A C Parrott; E Sisk; J J Turner
Journal:  Drug Alcohol Depend       Date:  2000-07-01       Impact factor: 4.492

5.  Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: a functional magnetic resonance imaging (fMRI) study.

Authors:  Jörg Daumann; Bruno Fimm; Klaus Willmes; Armin Thron; Euphrosyne Gouzoulis-Mayfrank
Journal:  Brain Res Cogn Brain Res       Date:  2003-05

Review 6.  (+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals.

Authors:  G A Ricaurte; J Yuan; U D McCann
Journal:  Neuropsychobiology       Date:  2000       Impact factor: 2.328

7.  Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

Authors:  U D McCann; Z Szabo; U Scheffel; R F Dannals; G A Ricaurte
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

8.  Abnormal brain activation to visual stimulation in cocaine abusers.

Authors:  Jing-Huei Lee; Frank W Telang; Charles S Springer; Nora D Volkow
Journal:  Life Sci       Date:  2003-08-29       Impact factor: 5.037

9.  Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.

Authors:  A C Parrott; J Lasky
Journal:  Psychopharmacology (Berl)       Date:  1998-10       Impact factor: 4.530

10.  Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.

Authors:  R Thomasius; K Petersen; R Buchert; B Andresen; P Zapletalova; L Wartberg; B Nebeling; A Schmoldt
Journal:  Psychopharmacology (Berl)       Date:  2003-03-11       Impact factor: 4.530

View more
  18 in total

1.  fNIRS suggests increased effort during executive access in ecstasy polydrug users.

Authors:  C A Roberts; C Montgomery
Journal:  Psychopharmacology (Berl)       Date:  2014-11-14       Impact factor: 4.530

Review 2.  Are executive function and impulsivity antipodes? A conceptual reconstruction with special reference to addiction.

Authors:  Warren K Bickel; David P Jarmolowicz; E Terry Mueller; Kirstin M Gatchalian; Samuel M McClure
Journal:  Psychopharmacology (Berl)       Date:  2012-03-24       Impact factor: 4.530

3.  MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex.

Authors:  Giulia Costa; Nicola Simola; Micaela Morelli
Journal:  Psychopharmacology (Berl)       Date:  2014-04-01       Impact factor: 4.530

4.  Prior MDMA (Ecstasy) use is associated with increased basal ganglia-thalamocortical circuit activation during motor task performance in humans: an fMRI study.

Authors:  John Karageorgiou; Mary S Dietrich; Evonne J Charboneau; Neil D Woodward; Jennifer U Blackford; Ronald M Salomon; Ronald L Cowan
Journal:  Neuroimage       Date:  2009-03-02       Impact factor: 6.556

5.  MDMA (Ecstasy) association with impaired fMRI BOLD thalamic coherence and functional connectivity.

Authors:  Ronald M Salomon; John Karageorgiou; Mary S Dietrich; Jessica Y McLellan; Evonne J Charboneau; Jennifer U Blackford; Ronald L Cowan
Journal:  Drug Alcohol Depend       Date:  2011-07-31       Impact factor: 4.492

6.  Incidental use of ecstasy: no evidence for harmful effects on cognitive brain function in a prospective fMRI study.

Authors:  Gerry Jager; Maartje M de Win; Hylke K Vervaeke; Thelma Schilt; Rene S Kahn; Wim van den Brink; Jan M van Ree; Nick F Ramsey
Journal:  Psychopharmacology (Berl)       Date:  2007-05-03       Impact factor: 4.530

7.  Neuroimaging in human MDMA (Ecstasy) users.

Authors:  Ronald L Cowan; Deanne M Roberts; James M Joers
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

8.  P50, N100, and P200 sensory gating: relationships with behavioral inhibition, attention, and working memory.

Authors:  Marijn Lijffijt; Scott D Lane; Stacey L Meier; Nash N Boutros; Scott Burroughs; Joel L Steinberg; F Gerard Moeller; Alan C Swann
Journal:  Psychophysiology       Date:  2009-06-08       Impact factor: 4.016

9.  Memory-related hippocampal functioning in ecstasy and amphetamine users: a prospective fMRI study.

Authors:  Benjamin Becker; Daniel Wagner; Philip Koester; Katja Bender; Christoph Kabbasch; Euphrosyne Gouzoulis-Mayfrank; Jörg Daumann
Journal:  Psychopharmacology (Berl)       Date:  2012-09-23       Impact factor: 4.530

Review 10.  Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview.

Authors:  João Paulo Capela; Helena Carmo; Fernando Remião; Maria Lourdes Bastos; Andreas Meisel; Félix Carvalho
Journal:  Mol Neurobiol       Date:  2009-04-17       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.